|
Signal Transduction
Citations 251-260 of 1930 total displayed.
|
Past content
(since May 2000):
|
Tumor necrosis factor  (TNF-) receptor-II is required for TNF-–induced leukocyte-endothelial interaction in vivo
- Unni M. Chandrasekharan, Maria Siemionow, Murat Unsal, Lin Yang, Earl Poptic, Justin Bohn, Kagan Ozer, Zhongmin Zhou, Philip H. Howe, Marc Penn, and Paul E. DiCorleto
Blood 2007; 109: 1938-1944.
[Abstract]
[Full text]
[PDF]
Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide–mediated vascular smooth muscle relaxation
- Jeff S. Isenberg, Fuminori Hyodo, Ken-Ichiro Matsumoto, Martin J. Romeo, Mones Abu-Asab, Maria Tsokos, Periannan Kuppusamy, David A. Wink, Murali C. Krishna, and David D. Roberts
Blood 2007; 109: 1945-1952.
[Abstract]
[Full text]
[PDF]
Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells
- Laurent David, Christine Mallet, Sabine Mazerbourg, Jean-Jacques Feige, and Sabine Bailly
Blood 2007; 109: 1953-1961.
[Abstract]
[Full text]
[PDF]
Cooperation between VEGF and ß3 integrin during cardiac vascular development
- Sara M. Weis, Jeffrey N. Lindquist, Leo A. Barnes, Kimberly M. Lutu-Fuga, Jianhua Cui, Malcolm R. Wood, and David A. Cheresh
Blood 2007; 109: 1962-1970.
[Abstract]
[Full text]
[PDF]
mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets
- Andrew S. Weyrich, Melvin M. Denis, Hansjorg Schwertz, Neal D. Tolley, Jason Foulks, Eliott Spencer, Larry W. Kraiss, Kurt H. Albertine, Thomas M. McIntyre, and Guy A. Zimmerman
Blood 2007; 109: 1975-1983.
[Abstract]
[Full text]
[PDF]
Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells
- Natasha K. Crellin, Rosa V. Garcia, and Megan K. Levings
Blood 2007; 109: 2014-2022.
[Abstract]
[Full text]
[PDF]
IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo
- Anja Fröhlich, Benjamin J. Marsland, Ivo Sonderegger, Michael Kurrer, Martin R. Hodge, Nicola L. Harris, and Manfred Kopf
Blood 2007; 109: 2023-2031.
[Abstract]
[Full text]
[PDF]
ZAP-70 enhances B-cell–receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells
- Stefania Gobessi, Luca Laurenti, Pablo G. Longo, Simona Sica, Giuseppe Leone, and Dimitar G. Efremov
Blood 2007; 109: 2032-2039.
[Abstract]
[Full text]
[PDF]
Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemias
- Ellen Weisberg, Laurie Catley, Renee D. Wright, Daisy Moreno, Lolita Banerji, Arghya Ray, Paul W. Manley, Juergen Mestan, Doriano Fabbro, Jingrui Jiang, Elizabeth Hall-Meyers, Linda Callahan, Jamie L. DellaGatta, Andrew L. Kung, and James D. Griffin
Blood 2007; 109: 2112-2120.
[Abstract]
[Full text]
[PDF]
MEK blockade converts AML differentiating response to retinoids into extensive apoptosis
- Michele Milella, Marina Konopleva, Cristina M. Precupanu, Yoko Tabe, Maria Rosaria Ricciardi, Chiara Gregorj, Steven J. Collins, Bing Z. Carter, Carmen D'Angelo, Maria Teresa Petrucci, Robin Foà, Francesco Cognetti, Agostino Tafuri, and Michael Andreeff
Blood 2007; 109: 2121-2129.
[Abstract]
[Full text]
[PDF]
|
|
